logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Martin Reck

LungenClinic Grosshansdorf

79H-index
638Paper Count
5.8WCitation Count
Published Papers 149
Publication Date
logo
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315)
errCancers
IF4.4
err2026-08-17
err0
errOAAI
errMartin Stuschke; Michael Thomas; Andreas Gröschel; Martin Sebastian; Martin Reck; Petra Hoffknecht; Christian Grah; Lisa Spring; Martina Jänicke; Carolin Lennartz; Paula Ludwig; Annika Groth; Parvis Sadjadian; Petros Christopoulos; Daniel Christian Christoph; Frank Griesinger; Bernward Passlick
errShare
errSave
Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis
erreClinicalMedicine
IF10
err2025-09-02
err0
PREAI
errSara Oresti; Fabio Salomone; Antonio Nuccio; Francesca Rita Ogliari; Silvia Teresa Riva; Ludovica Mollica; Alessandra Bulotta; Maria Grazia Viganò; Francesco Maria Venanzi; Francesco Passaretti; Ludovica Papotto; Anna Di Lello; Michele Ferrara; Giorgia Foggetti; Giuseppe Damiano; Alberto Servetto; Raffaele Califano; Massimo Di Maio; Biagio Ricciuti; Alessio Cortellini; Martin Reck; Michela Cinquini; Valter Torri; Giuseppe Viscardi; Roberto Ferrara
errShare
errSave
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
errlancet
IF0
err2025-08-07
err0
PREAI
errFabrice Barlesi; Wenxiu Yao; Michaël Duruisseaux; Ludovic Doucet; Aitor Azkárate Martínez; Vanesa Gregorc; Oscar Juan-Vidal; Shun Lu; Charlotte De Bondt; Filippo de Marinis; Helena Linardou; Young-Chul Kim; Robert Jotte; Enriqueta Felip; Giuseppe Lo Russo; Martin Reck; Mary F Michenzie; Wenjing Yang; Julie N Meade; Beata Korytowsky; Tony S K Mok
errShare
errSave
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)
errClinical & Experimental Metastasis
IF3.2
err2025-07-24
err0
errOAAI
errFarastuk Bozorgmehr; Inn Chung; Jürgen R. Fischer; Marc Bischof; Akin Atmaca; Sophie Wetzel; Martin Faehling; Dirk Bottke; Martin Wermke; Esther G. C. Troost; Cornelia Kropf-Sanchen; Thomas Wiegel; Bernd Schmidt; Andrej Stupavsky; Walburga Engel-Riedel; Michaela Hammer-Hellmig; Niels Reinmuth; Farkhad Manapov; Christian Grohe; Robert Krempien; Christian Schumann; Florian Sterzing; Martin Reck; Florian Würschmidt; Jochen Fleckenstein; Alev Petroff; Sven Henschke; Rouven Behnisch; Jelena Cvetkovic; Lena Brückner; Constantin Schwab; Albrecht Stenzinger; Thorsten Götze; Christina Kopp; Helge Schröder; Jürgen Debus; Petros Christopoulos; Michael Thomas; Stefan Rieken
errShare
errSave
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study
errJournal of Thoracic Oncology
IF20.8
err2025-07-22
err0
PREAI
errSolange Peters; Christian Schulz; Martin Reck; Kumar Prabhash; Dariusz Kowalski; Aleksandra Szczesna; Baohui Han; Achim Rittmeyer; Toby Talbot; David Vicente; Raffaele Califano; Diego Cortinovis; Anh Tuan Le; Dingzhi Huang; Geoffrey Liu; Federico Cappuzzo; Jessica Reyes Contreras; Ramon Palmero; Milena Perez Mak; Sanjay Popat; Youyou Hu; Stefanie Morris; Minu K. Srivastava; Monika Kaul; Vilma Graupner; Barbara Gitlitz; Siow Ming Lee
errShare
errSave
Response to the letter Re: “Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial”
errEuropean Journal of Cancer
IF7.1
err2025-07-08
err0
PREAI
errMartin Reck; Luis G. Paz-Ares
errShare
errSave
Updated treatment recommendations for systemic treatment: from the ESMO non-oncogene-addicted-metastatic NSCLC Living Guideline
errAnnals of Oncology
IF65.4
err2025-06-19
err0
PREAI
errL.E.L. Hendriks; F. Cortiula; D. Martins-Branco; E. Mariamidze; S. Popat; M. Reck
errShare
errSave
Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer—final analysis from the phase II PACIFIC-6 trial
errESMO Open
IF8.3
err2025-06-01
err0
errOAAI
errM.C. Garassino; J. Khalifa; M. Reck; C. Chouaid; H. Bischoff; N. Reinmuth; L. Cove-Smith; T. Mansy; D.L. Cortinovis; M.R. Migliorino; A. Delmonte; J. Garcia Sánchez; L.E. Chara Velarde; R. Bernabe; L. Paz-Ares; P. Chander; I. Diaz Perez; K. Foroutanpour; U. Emeribe; C. Faivre-Finn
errShare
errSave
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLC
errBRITISH JOURNAL OF CANCER
IF6.8
err2025-05-03
err0
errOAAI
errNitschkowski, Doerte; Vierbuchen, Tim; Heine, Holger; Behrends, Jochen; Reiling, Norbert; Reck, Martin; Rabe, Klaus F.; Kugler, Christian; Ammerpohl, Ole; Droemann, Daniel; Muley, Thomas; Kriegsmann, Mark; Stathopoulos, Georgious T.; Arendt, Kristina A. M.; Goldmann, Torsten; Marwitz, Sebastian
errShare
errSave
Existential distress in advanced cancer: A cohort study
errGENERAL HOSPITAL PSYCHIATRY
IF3.7
err2025-05-01
err0
PREAI
errPhilipp, Rebecca; Walbaum, Charlotte; Koch, Uwe; Oechsle, Karin; Daniels, Thies; Helmich, Friederike; Horn, Marlitt; Junghans, Johanna; Kissane, David; Lock, Guntram; Lo, Christopher; Mruk-Kahl, Anne; Mueller, Volkmar; Reck, Martin; Schilling, Georgia; Schulze, Kornelius; von Felden, Johann; Bokemeyer, Carsten; Haerter, Martin; Vehling, Sigrun
errShare
errSave
Red blood cell-tumor cell interactions promote tumor cell progression
errJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
err2025-04-29
err0
errOAAI
errPereira-Veiga, Thais; Yanez-Gomez, Celso; Pekkarinen, Aleksi; Abuin, Carmen; Blechner, Christine; Gonzalez-Conde, Miriam; Mess, Christian; Vidal-y-Sy, Sabine; Moustafa, Ayham; Siebels, Bente; Davila-Ibanez, Ana B.; Cabezas-Sainz, Pablo; Santos, Maider; Sanchez, Laura; Gorgulho, Joao; Goetze, Julian; Meissner, Kira; Cueva, Juan; Palacios, Patricia; Cortegoso, Alexandra; Curiel, Teresa; Rodriguez, Carmela; Carmona, Marta; Leon-Mateos, Luis; Abalo, Alicia; Muinelo-Romay, Laura; Peine, Sven; Schmidt, Milena; Heuer-Olewinski, Nadine; Reck, Martin; Abdo, Mustafa; Lamszus, Katrin; Bauer, Alexander T.; Lopez-Lopez, Rafael; Pantel, Klaus; Windhorst, Sabine; Costa, Clotilde
errShare
errSave
Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial
errADVANCES IN THERAPY
IF4
err2025-03-01
err0
errOAAI
errHummel, Horst-Dieter; Ahn, Myung-Ju; Blackhall, Fiona; Reck, Martin; Akamatsu, Hiroaki; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa; Dirnberger, Franziska; Cocks, Kim; Huang, Shuang; Mukherjee, Sujoy; Paz-Ares, Luis
errShare
errSave
Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2025-02-01
err0
errOAAI
errNishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Nishio, Kazuto; Kasahara, Kazuo; Nishino, Kazumi; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Sakai, Kazuko; Enatsu, Sotaro; Frimodt-Moller, Bente; Matsui, Tomoko; Varughese, Sunoj Chacko; Carlsen, Michelle; Visseren-Grul, Carla; Nakagawa, Kazuhiko
errShare
errSave
A non-interventional biomarker study in patients with adenocarcinoma of the lung treated with nintedanib plus docetaxel following progression on chemotherapy and/or immunotherapy: LUME-BioNIS
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2024-12-01
err0
errOAAI
errReck, Martin; Syrigos, Konstantinos; Miliauskas, Skaidrius; Westeinde, Susan C. van't; Massuti, Bartomeu; Buchner, Hannes; V. Salnikov, Alexey; Lorence, Robert M.; Ellingboe, Anne-Marit; Kitzing, Thomas; Kerr, Keith
errShare
errSave
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer
errFUTURE ONCOLOGY
IF2.6
err2024-11-12
err0
errOAAI
errAhn, Myung-Ju; Cho, Byoung Chul; Felip, Enriqueta; Korantzis, Ippokratis; Ohashi, Kadoaki; Majem, Margarita; Juan-Vidal, Oscar; Handzhiev, Sabin; Izumi, Hiroki; Lee, Jong-Seok; Dziadziuszko, Rafal; Wolf, Juergen; Blackhall, Fiona; Reck, Martin; Alvarez, Jean Bustamante; Hummel, Horst-Dieter; Dingemans, Anne-Marie C.; Sands, Jacob; Akamatsu, Hiroaki; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa L.; Huang, Shuang; Mukherjee, Sujoy; Minocha, Mukul; Jiang, Tony; Martinez, Pablo; Anderson, Erik S.; Paz-Ares, Luis
errShare
errSave
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2024-11-01
err5
PREAI
errNakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin
errShare
errSave
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities
errVIRCHOWS ARCHIV
IF3.1
err2024-10-08
err0
errOAAI
errMoeller, Katharina; Gulzar, Tayyaba; Lennartz, Maximilian; Viehweger, Florian; Kluth, Martina; Hube-Magg, Claudia; Bernreuther, Christian; Bawahab, Ahmed Abdulwahab; Simon, Ronald; Clauditz, Till S.; Sauter, Guido; Schlichter, Ria; Hinsch, Andrea; Kind, Simon; Jacobsen, Frank; Burandt, Eike; Frost, Nikolaj; Reck, Martin; Marx, Andreas H.; Krech, Till; Lebok, Patrick; Fraune, Christoph; Steurer, Stefan
errShare
errSave
Tucatinib and Trastuzumab for Patients With Previously Treated, HER2-Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-10-01
err0
PREAI
errNakamura, Y.; Bekaii-Saab, T.; Hamilton, E.; Hayashi, H.; Mizuno, N.; Monk, B. J.; Nguyen, D.; Okines, A.; O'Malley, D. M.; Pohlmann, P. R.; Pothuri, B.; Reck, M.; Sudo, K.; Sunakawa, Y.; Takahashi, S.; Yu, E. Y.; Drees, A.; Tan, S.; Stinchcombe, T. E.
errShare
errSave
PET/CT-guided immune checkpoint blocker treatment discontinuation vs treatment continuation in lung cancer long-term responders: A National Network Genomic Medicine Lung Cancer Germany (nNGM) analysis
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errFrost, N.; Wiesweg, M.; Rasokat, A.; Kulhavy, J.; Kollmeier, J.; Reinmuth, N.; Lueders, H.; Roeper, J.; Rittmeyer, A.; Heinzen, S.; Saalfeld, F. C.; Wesseler, C.; Kauffmann-Guerrero, D.; Christopoulos, P.; Kemper, M.; Collienne, M.; Berezucki, E.; Overbeck, T. R.; Kropf, C.; Reck, M.
errShare
errSave
IMpower010: ctDNA status and 5y DFS follow up in patients (pts) with resected NSCLC who received adjuvant chemotherapy (chemo) followed by atezolizumab (atezo) or best supportive care (BSC)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errWakelee, H.; Reck, M.; Felip, E.; Altorki, N. K.; Vallieres, E.; Liersch, R.; Oizumi, S.; Tanaka, H.; Hamm, J. T.; McCune, S.; Bennett, E.; Gitlitz, B. J.; McNally, V. A.; Novello, S.; Ballinger, M.; Zou, W.; Nabet, B.; Srivastava, M.; Zhou, C.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
T
Tony Mok
H-index: 131 · Papers: 1.1K
E
Enriqueta Felip
H-index: 129 · Papers: 1.5K
J
John V. Heymach
H-index: 128 · Papers: 2.4K
View more